Global Bispecific Antibodies Market to 2035: Players Include Akeso Biopharma, Amgen, Astrazeneca, Genmab and Immunocore
July 07, 2023 07:18 ET
|
Research and Markets
Dublin, July 07, 2023 (GLOBE NEWSWIRE) -- The "Bispecific Antibodies Market 2023-2035" report has been added to ResearchAndMarkets.com's offering. This report features an extensive study of the...
Global Immuno-Oncology Thematic Intelligence Report 2023: Focus on Trends in Bispecific Antibodies, Cancer Vaccines, Cell Therapies, Checkpoint Modulators, Cytokines, & Oncolytic Viruses
June 13, 2023 04:48 ET
|
Research and Markets
Dublin, June 13, 2023 (GLOBE NEWSWIRE) -- The "Immuno-Oncology - Thematic Intelligence" report has been added to ResearchAndMarkets.com's offering.This report includes coverage of immuno-oncology...
Global T-Cell Immunotherapy Market Report 2023: Increasing Prevalence of Cancer and Autoimmune Diseases Boosts Demand
May 26, 2023 09:03 ET
|
Research and Markets
Dublin, May 26, 2023 (GLOBE NEWSWIRE) -- The "Global T-Cell Immunotherapy Market by Mechanism Of Action (Active Immunotherapy, Passive Immunotherapy), Product Class (Bispecific Antibodies,...
Global Bispecific Antibody Market Report 2023: Players Include Astellas Pharma, AstraZeneca, BioAtla, BJ Bioscience and EpimAb Biotherapeutics
May 16, 2023 06:18 ET
|
Research and Markets
Dublin, May 16, 2023 (GLOBE NEWSWIRE) -- The "Global Bispecific Antibody Market Opportunity and Clinical Trials Insight 2023" report has been added to ResearchAndMarkets.com's offering.Report...
Global Digital Biomanufacturing Market Report 2023: Growing Number of Biologics-related Clinical Trials Fuels the Sector
May 01, 2023 04:58 ET
|
Research and Markets
Dublin, May 01, 2023 (GLOBE NEWSWIRE) -- The "Digital Biomanufacturing Market - Distribution by Type of Technology, Deployment Options, Types of Biologics Manufactured, and Key Geographical Regions:...
Neuroendocrine Tumor Treatment Global Market Report 2023: Developments and Approval of Novel Drugs to Boost Growth
March 28, 2023 09:13 ET
|
Research and Markets
Dublin, March 28, 2023 (GLOBE NEWSWIRE) -- The "Neuroendocrine Tumor Treatment Market - Global Industry Size, Share, Trends, Competition, Opportunity and Forecast, 2018-2028 Segmented By Product...
Global Bispecific Antibodies for Cancer Market Report 2023-2027: Increasing Prevalence of Cancer, Advantages of Bispecific Antibodies Over Monoclonal Antibodies, and Strong Pipeline Drives Growth
March 15, 2023 07:03 ET
|
Research and Markets
Dublin, March 15, 2023 (GLOBE NEWSWIRE) -- The "Global Bispecific Antibodies for Cancer Market 2023-2027" report has been added to ResearchAndMarkets.com's offering.The bispecific antibodies for...
NovalGen appoints Dr Michael Owen and Mr Scott Clark to the Board of Directors
January 09, 2023 07:00 ET
|
NovalGen Ltd.
LONDON, Jan. 09, 2023 (GLOBE NEWSWIRE) -- NovalGen Ltd (“NovalGen”), a biopharmaceutical company developing breakthrough cancer therapies, alongside a disruptive auto-regulation platform, today...
Cadherin 17 Target Analysis Report 2022: Opportunity for Drug Discovery and Development as the Landscape is Very Favorable for New Entrants Evan as the 1st Molecules have Entered Clinical Development
December 16, 2022 04:28 ET
|
Research and Markets
Dublin, Dec. 16, 2022 (GLOBE NEWSWIRE) -- The "Cadherin 17: A Target Opportunity To Develop Effector-Enhanced Drug Modalities" report has been added to ResearchAndMarkets.com's offering. CDH17...
NovalGen announces one oral and two poster presentations at the American Society of Hematology Annual Meeting
November 03, 2022 09:58 ET
|
NovalGen Ltd.
-Updated clinical data for NVG-111, a novel ROR1xCD3 bispecific antibody in patients with relapsed / refractory CLL and MCL -- Pre-clinical data for a first in class half-life extended T Cell engager...